메뉴 건너뛰기




Volumn 104, Issue 1, 2011, Pages 1-2

Is surgical resection still the treatment of choice for early hepatocellular carcinoma?

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; DECARBOXYPROTHROMBIN; INDOCYANINE GREEN; IODINATED POPPYSEED OIL; TUMOR MARKER;

EID: 79958095017     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21765     Document Type: Editorial
Times cited : (3)

References (6)
  • 1
    • 28844480321 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma
    • DOI 10.1002/hep.20933
    • Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236. (Pubitemid 43112690)
    • (2005) Hepatology , vol.42 , Issue.5 , pp. 1208-1236
    • Bruix, J.1    Sherman, M.2
  • 2
    • 38649141497 scopus 로고    scopus 로고
    • Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?
    • DOI 10.1002/hep.21933
    • Livraghi T, Meloni F, Di Stasi M, et al.: Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008;47:82-89. (Pubitemid 351171044)
    • (2008) Hepatology , vol.47 , Issue.1 , pp. 82-89
    • Livraghi, T.1    Meloni, F.2    Di, S.M.3    Rolle, E.4    Solbiati, L.5    Tinelli, C.6    Rossi, S.7
  • 3
    • 84878749781 scopus 로고    scopus 로고
    • Treatment strategy for early hepatocellular carcinomas: Comparison of radiofrequency ablation with or without transarterial chemoembolization and surgical resection
    • 00
    • Tashiro H, Aikata H, Waki K, et al.: Treatment strategy for early hepatocellular carcinomas: Comparison of radiofrequency ablation with or without transarterial chemoembolization and surgical resection. J Surg Oncol 2010;00:X-X.
    • (2010) J Surg Oncol
    • Tashiro, H.1    Aikata, H.2    Waki, K.3
  • 4
    • 77954352223 scopus 로고    scopus 로고
    • Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: Ameta-analysis
    • Wang W, Shi J, Xie WF: Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: ameta-analysis. Liver Int 2010;30:741-749.
    • (2010) Liver Int , vol.30 , pp. 741-749
    • Wang, W.1    Shi, J.2    Xie, W.F.3
  • 5
    • 45549093419 scopus 로고    scopus 로고
    • Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma
    • Lam VW, Ng KK, Chok KS, et al.: Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg 2008;207:20-29.
    • (2008) J Am Coll Surg , vol.207 , pp. 20-29
    • Lam, V.W.1    Ng, K.K.2    Chok, K.S.3
  • 6
    • 33644662778 scopus 로고    scopus 로고
    • A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma
    • DOI 10.1097/01.sla.0000201480.65519.b8
    • Chen MS, Li JQ, Zheng Y, et al.: A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243:321-328. (Pubitemid 43327762)
    • (2006) Annals of Surgery , vol.243 , Issue.3 , pp. 321-328
    • Chen, M.-S.1    Li, J.-Q.2    Zheng, Y.3    Guo, R.-P.4    Liang, H.-H.5    Zhang, Y.-Q.6    Lin, X.-J.7    Lau, W.Y.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.